These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19879230)

  • 1. Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old.
    Rauw F; Gardin Y; Palya V; Anbari S; Lemaire S; Boschmans M; van den Berg T; Lambrecht B
    Vaccine; 2010 Jan; 28(3):823-33. PubMed ID: 19879230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset and long-term duration of immunity provided by a single vaccination with a turkey herpesvirus vector ND vaccine in commercial layers.
    Palya V; Tatár-Kis T; Mató T; Felföldi B; Kovács E; Gardin Y
    Vet Immunol Immunopathol; 2014 Mar; 158(1-2):105-15. PubMed ID: 24368086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
    Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
    Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine.
    Rauw F; Gardin Y; Palya V; Anbari S; Gonze M; Lemaire S; van den Berg T; Lambrecht B
    Vet Immunol Immunopathol; 2010 Apr; 134(3-4):249-58. PubMed ID: 19939464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
    Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
    Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of attenuated Newcastle disease (ND) vaccine with rHVT-ND vaccine at 1 day old is more protective against ND virus challenge than when combined with inactivated ND vaccine.
    Rauw F; Gardin Y; Palya V; van den Berg T; Lambrecht B
    Avian Pathol; 2014; 43(1):26-36. PubMed ID: 24283258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity Elicited by a Turkey Herpesvirus-Vectored Newcastle Disease Vaccine in Turkey Against Challenge With a Recent Genotype IV Newcastle Disease Virus Field Strain.
    El Khantour A; Darkaoui S; Tatár-Kis T; Mató T; Essalah-Bennani A; Cazaban C; Palya V
    Avian Dis; 2017 Sep; 61(3):378-386. PubMed ID: 28957008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
    Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
    Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of recombinant herpesvirus of turkey expressing genes of infectious laryngotracheitis virus in specific pathogen free and broiler chickens following in ovo and subcutaneous vaccination.
    Gimeno IM; Cortes AL; Guy JS; Turpin E; Williams C
    Avian Pathol; 2011 Aug; 40(4):395-403. PubMed ID: 21812719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
    Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
    J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
    Stone H; Mitchell B; Brugh M
    Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens.
    Heckert RA; Riva J; Cook S; McMillen J; Schwartz RD
    Avian Dis; 1996; 40(4):770-7. PubMed ID: 8980804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens.
    Ferreira HL; Reilley AM; Goldenberg D; Ortiz IRA; Gallardo RA; Suarez DL
    Vaccine; 2020 Jul; 38(34):5507-5515. PubMed ID: 32591288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens.
    Reddy SK; Sharma JM; Ahmad J; Reddy DN; McMillen JK; Cook SM; Wild MA; Schwartz RD
    Vaccine; 1996 Apr; 14(6):469-77. PubMed ID: 8782342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral, cell-mediated and mucosal immunity induced by oculo-nasal vaccination of one-day-old SPF and conventional layer chicks with two different live Newcastle disease vaccines.
    Rauw F; Gardin Y; Palya V; van Borm S; Gonze M; Lemaire S; van den Berg T; Lambrecht B
    Vaccine; 2009 Jun; 27(27):3631-42. PubMed ID: 19464544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
    King DJ
    Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.